Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Antibody Dependent Enhancement of Acinetobacter baumannii Infection in a Mouse Pneumonia Model.

Wang-Lin SX, Olson R, Beanan JM, MacDonald U, Russo TA, Balthasar J.

J Pharmacol Exp Ther. 2019 Jan 3. pii: jpet.118.253617. doi: 10.1124/jpet.118.253617. [Epub ahead of print]

2.

The Capsular Polysaccharide of Acinetobacter baumannii Is an Obstacle for Therapeutic Passive Immunization Strategies.

Wang-Lin SX, Olson R, Beanan JM, MacDonald U, Balthasar JP, Russo TA.

Infect Immun. 2017 Nov 17;85(12). pii: e00591-17. doi: 10.1128/IAI.00591-17. Print 2017 Dec.

3.

The Response Regulator BfmR Is a Potential Drug Target for Acinetobacter baumannii.

Russo TA, Manohar A, Beanan JM, Olson R, MacDonald U, Graham J, Umland TC.

mSphere. 2016 May 11;1(3). pii: e00082-16. doi: 10.1128/mSphere.00082-16. eCollection 2016 May-Jun.

4.

Structure of shikimate kinase, an in vivo essential metabolic enzyme in the nosocomial pathogen Acinetobacter baumannii, in complex with shikimate.

Sutton KA, Breen J, MacDonald U, Beanan JM, Olson R, Russo TA, Schultz LW, Umland TC.

Acta Crystallogr D Biol Crystallogr. 2015 Aug;71(Pt 8):1736-44. doi: 10.1107/S139900471501189X. Epub 2015 Jul 31.

PMID:
26249354
5.

The K1 capsular polysaccharide from Acinetobacter baumannii is a potential therapeutic target via passive immunization.

Russo TA, Beanan JM, Olson R, MacDonald U, Cox AD, St Michael F, Vinogradov EV, Spellberg B, Luke-Marshall NR, Campagnari AA.

Infect Immun. 2013 Mar;81(3):915-22. doi: 10.1128/IAI.01184-12. Epub 2013 Jan 7.

6.

In vivo-validated essential genes identified in Acinetobacter baumannii by using human ascites overlap poorly with essential genes detected on laboratory media.

Umland TC, Schultz LW, MacDonald U, Beanan JM, Olson R, Russo TA.

MBio. 2012 Aug 31;3(4). pii: e00113-12. doi: 10.1128/mBio.00113-12. Print 2012.

7.

Biofilm formed by a hypervirulent (hypermucoviscous) variant of Klebsiella pneumoniae does not enhance serum resistance or survival in an in vivo abscess model.

Kong Q, Beanan JM, Olson R, Macdonald U, Shon AS, Metzger DJ, Pomakov AO, Russo TA.

Virulence. 2012 May 1;3(3):309-18. doi: 10.4161/viru.20383. Epub 2012 May 1.

8.

Hypervirulent K. pneumoniae secretes more and more active iron-acquisition molecules than "classical" K. pneumoniae thereby enhancing its virulence.

Russo TA, Shon AS, Beanan JM, Olson R, MacDonald U, Pomakov AO, Visitacion MP.

PLoS One. 2011;6(10):e26734. doi: 10.1371/journal.pone.0026734. Epub 2011 Oct 24.

9.

Clinical and phenotypic differences between classic and hypervirulent Klebsiella pneumonia: an emerging and under-recognized pathogenic variant.

Pomakova DK, Hsiao CB, Beanan JM, Olson R, MacDonald U, Keynan Y, Russo TA.

Eur J Clin Microbiol Infect Dis. 2012 Jun;31(6):981-9. doi: 10.1007/s10096-011-1396-6. Epub 2011 Sep 15.

PMID:
21918907
10.

In vivo and in vitro activity of the siderophore monosulfactam BAL30072 against Acinetobacter baumannii.

Russo TA, Page MG, Beanan JM, Olson R, Hujer AM, Hujer KM, Jacobs M, Bajaksouzian S, Endimiani A, Bonomo RA.

J Antimicrob Chemother. 2011 Apr;66(4):867-73. doi: 10.1093/jac/dkr013. Epub 2011 Feb 13.

11.

The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor.

Russo TA, Luke NR, Beanan JM, Olson R, Sauberan SL, MacDonald U, Schultz LW, Umland TC, Campagnari AA.

Infect Immun. 2010 Sep;78(9):3993-4000. doi: 10.1128/IAI.00366-10. Epub 2010 Jul 19.

12.

Identification and characterization of a glycosyltransferase involved in Acinetobacter baumannii lipopolysaccharide core biosynthesis.

Luke NR, Sauberan SL, Russo TA, Beanan JM, Olson R, Loehfelm TW, Cox AD, St Michael F, Vinogradov EV, Campagnari AA.

Infect Immun. 2010 May;78(5):2017-23. doi: 10.1128/IAI.00016-10. Epub 2010 Mar 1.

13.

Penicillin-binding protein 7/8 contributes to the survival of Acinetobacter baumannii in vitro and in vivo.

Russo TA, MacDonald U, Beanan JM, Olson R, MacDonald IJ, Sauberan SL, Luke NR, Schultz LW, Umland TC.

J Infect Dis. 2009 Feb 15;199(4):513-21. doi: 10.1086/596317.

PMID:
19143563
14.

Capsular polysaccharide and the O-specific antigen impede antibody binding: a potential obstacle for the successful development of an extraintestinal pathogenic Escherichia coli vaccine.

Russo TA, Beanan JM, Olson R, MacDonald U, Cope JJ.

Vaccine. 2009 Jan 14;27(3):388-95. doi: 10.1016/j.vaccine.2008.10.082. Epub 2008 Nov 17.

PMID:
19014988
15.

Rat pneumonia and soft-tissue infection models for the study of Acinetobacter baumannii biology.

Russo TA, Beanan JM, Olson R, MacDonald U, Luke NR, Gill SR, Campagnari AA.

Infect Immun. 2008 Aug;76(8):3577-86. doi: 10.1128/IAI.00269-08. Epub 2008 Jun 9.

16.

Capsule and O-antigen from an extraintestinal isolate of Escherichia coli modulate cytokine levels in rat macrophages in vitro and in a rat model of pneumonia.

Russo TA, Davidson BA, Beanan JM, Olson R, Holm BA, Notter RH, Knight PR 3rd.

Exp Lung Res. 2007 Sep;33(7):337-56.

PMID:
17849261
17.

Surfactant dysfunction and lung injury due to the E. coli virulence factor hemolysin in a rat pneumonia model.

Russo TA, Wang Z, Davidson BA, Genagon SA, Beanan JM, Olson R, Holm BA, Knight PR 3rd, Chess PR, Notter RH.

Am J Physiol Lung Cell Mol Physiol. 2007 Mar;292(3):L632-43.

18.

A killed, genetically engineered derivative of a wild-type extraintestinal pathogenic E. coli strain is a vaccine candidate.

Russo TA, Beanan JM, Olson R, Genagon SA, MacDonald U, Cope JJ, Davidson BA, Johnston B, Johnson JR.

Vaccine. 2007 May 10;25(19):3859-70. Epub 2007 Feb 5.

19.

E. coli virulence factor hemolysin induces neutrophil apoptosis and necrosis/lysis in vitro and necrosis/lysis and lung injury in a rat pneumonia model.

Russo TA, Davidson BA, Genagon SA, Warholic NM, Macdonald U, Pawlicki PD, Beanan JM, Olson R, Holm BA, Knight PR 3rd.

Am J Physiol Lung Cell Mol Physiol. 2005 Aug;289(2):L207-16. Epub 2005 Apr 1.

20.

The Siderophore receptor IroN of extraintestinal pathogenic Escherichia coli is a potential vaccine candidate.

Russo TA, McFadden CD, Carlino-MacDonald UB, Beanan JM, Olson R, Wilding GE.

Infect Immun. 2003 Dec;71(12):7164-9.

21.

IroN functions as a siderophore receptor and is a urovirulence factor in an extraintestinal pathogenic isolate of Escherichia coli.

Russo TA, McFadden CD, Carlino-MacDonald UB, Beanan JM, Barnard TJ, Johnson JR.

Infect Immun. 2002 Dec;70(12):7156-60.

Supplemental Content

Loading ...
Support Center